BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24240653)

  • 21. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling.
    Wolkewitz M; Beyersmann J; Gastmeier P; Schumacher M
    Methods Inf Med; 2009; 48(5):438-43. PubMed ID: 19657545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure-time-varying hazard function ratios in case-control studies of drug effects.
    Guess HA
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):81-92. PubMed ID: 16287211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semiparametric models for cumulative incidence functions.
    Bryant J; Dignam JJ
    Biometrics; 2004 Mar; 60(1):182-90. PubMed ID: 15032788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A maximum likelihood method for secondary analysis of nested case-control data.
    Salim A; Xiangmei M; Jialiang L; Reilly M
    Stat Med; 2014 May; 33(11):1842-52. PubMed ID: 24753004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating risk and rate levels, ratios and differences in case-control studies.
    King G; Zeng L
    Stat Med; 2002 May; 21(10):1409-27. PubMed ID: 12185893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence density matching with a simple SAS computer program.
    Pearce N
    Int J Epidemiol; 1989 Dec; 18(4):981-4. PubMed ID: 2621036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hazard rate models with covariates.
    Prentice RL; Kalbfleisch JD
    Biometrics; 1979 Mar; 35(1):25-39. PubMed ID: 497336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.
    Beyersmann J; Dettenkofer M; Bertz H; Schumacher M
    Stat Med; 2007 Dec; 26(30):5360-9. PubMed ID: 17634974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The analysis of case cohort design in the presence of competing risks with application to estimate the risk of delayed cardiac toxicity among Hodgkin lymphoma survivors.
    Pintilie M; Bai Y; Yun L; Hodgson DC
    Stat Med; 2010 Nov; 29(27):2802-10. PubMed ID: 20827727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure.
    Cologne JB; Sharp GB; Neriishi K; Verkasalo PK; Land CE; Nakachi K
    Int J Epidemiol; 2004 Jun; 33(3):485-92. PubMed ID: 15105408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining data from 2 nested case-control studies of overlapping cohorts to improve efficiency.
    Salim A; Hultman C; Sparén P; Reilly M
    Biostatistics; 2009 Jan; 10(1):70-9. PubMed ID: 18550564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving nested case-control studies to conduct a full competing-risks analysis for nosocomial infections.
    Hazard D; Schumacher M; Palomar-Martinez M; Alvarez-Lerma F; Olaechea-Astigarraga P; Wolkewitz M
    Infect Control Hosp Epidemiol; 2018 Oct; 39(10):1196-1201. PubMed ID: 30157989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of incidence and prognosis from 'extreme' case-control designs.
    Salim A; Ma X; Fall K; Andrén O; Reilly M
    Stat Med; 2014 Dec; 33(30):5388-98. PubMed ID: 24980445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum likelihood estimation for Cox's regression model under nested case-control sampling.
    Scheike TH; Juul A
    Biostatistics; 2004 Apr; 5(2):193-206. PubMed ID: 15054025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysing and interpreting competing risk data.
    Pintilie M
    Stat Med; 2007 Mar; 26(6):1360-7. PubMed ID: 16900575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bias from matching on age at death or censor in nested case-control studies.
    Hein MJ; Deddens JA; Schubauer-Berigan MK
    Epidemiology; 2009 May; 20(3):330-8. PubMed ID: 19289956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort.
    Wacholder S; Gail M; Pee D
    Biometrics; 1991 Mar; 47(1):63-76. PubMed ID: 2049514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.